Going Beyond Topical Steroids and Calcineurin Inhibitors for AD Treatment

The panel examines the evolution of atopic dermatitis (AD) treatment beyond topical steroids and calcineurin inhibitors, while evaluating the safety and efficacy of a specific topical therapy in AD management.

Related Videos
timothy caulfield, JD
dr ibrahim aldoss
dr anna sureda
Related Content
CH LogoCenter for Biosimilars Logo